Laurence Tisi

Laurence Tisi PhD, CEO

Laurence Tisi, CEO of ERBA Molecular and Co-founder of Lumora which was acquired by ERBA Mannheim in September 2015 to form ERBA Molecular. Laurence has been leading operations since 2003 and CEO since 2007, directing the R&D pipeline and day to day running of the company. He has helped Lumora raise £4.8M in funding before leading hugely successful exit for the investors and shareholders. He is a former winner of the 'Marlene Deluca Prize' for the research he performed on bioluminescence whilst at Cambridge University. He is a named inventor on several patents including Lumora's core 'BART' technology

Hayden JeffreysHayden Jeffreys, Commercial Director

Hayden Jeffreys ERBA Molecular Commercial Director (CCO). Hayden joined Lumora in 2013 as Commercial Director with a remit to further commercialise Lumora’s technologies including BART (Bioluminescent Assay in Real Time) as well as prepare the company for exit which was successfully achieved in September 2015. Hayden brings a wealth of experience from the molecular diagnostics industry which will be crucial to fulfilling ERBA Molecular duel strategy of licensing its technology to major commercial partners and . Before joining Lumora, Hayden was Divisional Director–Diagnostic Products at Lab21, and previously worked at Invitron, Gen-Probe and Molecular Light Technology.